These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 23291482)
21. [The significance of cardiovascular risk factors and C-reactive protein to the development of atherosclerosis in women with systemic lupus erythematosus]. Panafidina TA; Popkova TV; Alekberova ZS; Novikova PS; Mach ES; Aleksandrova EN; Kashnikova LN; Nasonov EL Klin Med (Mosk); 2006; 84(10):49-54. PubMed ID: 17201275 [TBL] [Abstract][Full Text] [Related]
22. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Salmon JE; Roman MJ Am J Med; 2008 Oct; 121(10 Suppl 1):S3-8. PubMed ID: 18926167 [TBL] [Abstract][Full Text] [Related]
23. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus. Mok CC; Poon WL; Lai JP; Wong CK; Chiu SM; Wong CK; Lun SW; Ko GT; Lam CW; Lam CS Scand J Rheumatol; 2010; 39(1):42-9. PubMed ID: 20132070 [TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus. Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J; J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903 [TBL] [Abstract][Full Text] [Related]
25. Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand? Nikpour M; Gladman DD; Urowitz MB Lupus; 2013 Oct; 22(12):1243-50. PubMed ID: 24097996 [TBL] [Abstract][Full Text] [Related]
27. Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus. de Leeuw K; Smit AJ; de Groot E; van Roon AM; Kallenberg CG; Bijl M Atherosclerosis; 2009 Oct; 206(2):546-50. PubMed ID: 19389674 [TBL] [Abstract][Full Text] [Related]
28. Systemic lupus erythematosus, atherosclerosis, and autoantibodies. Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977 [TBL] [Abstract][Full Text] [Related]
29. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus. Lee AB; Godfrey T; Rowley KG; Karschimkus CS; Dragicevic G; Romas E; Clemens L; Wilson AM; Nikpour M; Prior DL; Best JD; Jenkins AJ Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741 [TBL] [Abstract][Full Text] [Related]
30. Epidemiology of atherosclerosis in systemic lupus erythematosus. Nikpour M; Urowitz MB; Gladman DD Curr Rheumatol Rep; 2009 Aug; 11(4):248-54. PubMed ID: 19691927 [TBL] [Abstract][Full Text] [Related]
37. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis. George J; Harats D; Gilburd B; Levy Y; Langevitz P; Shoenfeld Y Lupus; 1999; 8(3):220-6. PubMed ID: 10342715 [TBL] [Abstract][Full Text] [Related]
38. The problem of accelerated atherosclerosis in systemic lupus erythematosus: insights into a complex co-morbidity. Wade NS; Major AS Thromb Haemost; 2011 Nov; 106(5):849-57. PubMed ID: 21979131 [TBL] [Abstract][Full Text] [Related]
39. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus? Narshi CB; Giles IP; Rahman A Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982 [TBL] [Abstract][Full Text] [Related]
40. The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus. Kahlenberg JM; Kaplan MJ Arthritis Res Ther; 2011 Feb; 13(1):203. PubMed ID: 21371346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]